Updated:
IGM Biosciences, Inc.
IGM Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001496323, and its reported industry...
Overview
IGM Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001496323, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-06, it reported net income of USD -195,795,000; total assets of USD 265,712,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- IGM Biosciences, Inc.
- Former names in filing history
- Palingen, Inc. (2010-07-16 to 2010-07-16)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Mountain View, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001496323
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$195.8M | $265.7M | $26.5M | -$153.0M | |
| FY2023USD | -$246.4M | $423.4M | $112.5M | -$192.2M | |
| FY2022USD | -$221.1M | $513.5M | $121.2M | -$5.9M | |
| FY2021USD | -$165.2M | $298.1M | $133.3M | -$124.3M |
FY2021. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research IGM Biosciences, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.